277 results on '"Dani, Sameer"'
Search Results
2. Correlation Between Ambulatory Blood Pressure Monitoring and Office Blood Pressure Measurement in Patients with Hypertension: A Community Study
3. Consensus document: management of heart failure in type 2 diabetes mellitus
4. Technical Insights on Drug-Coated Balloons II
5. Impact of the 2017 ACC/AHA guidelines on the prevalence of hypertension among Indian adults: Results from a cross-sectional survey
6. A novel nanocarrier sirolimus-coated balloon for coronary interventions: 12-Month data from the Nanoluté Registry
7. Self-blood pressure measurement as compared to office blood pressure measurement in a large Indian population; the India Heart Study
8. 213 Consensus towards the utilisation of bisoprolol in combination with telmisartan in indian patients with hypertension
9. Surgery versus Balloon angioplasty for treating coarctation of aorta: A meta-analysis
10. ESSENS dyslipidemia: A placebo-controlled, randomized study of a nutritional supplement containing red yeast rice in subjects with newly diagnosed dyslipidemia
11. Prevalence of sympathetic overactivity in hypertensive patients – A pan India, non-interventional, cross sectional study
12. Clinical outcomes with Biolimus (A9)™ eluting stent, ‘BioMatrix’ in diabetic patients – interim results from multicenter post market surveillance registry in India
13. Systemic exposure of sirolimus after coronary stent implantation in patients with de novo coronary lesions: Supralimus-Core® pharmacokinetic study
14. TCTAP A-043 Long-Term Safety and Efficacy Outcomes After Treatment of Coronary Artery Lesions Using Sirolimus Coated Balloons: Insights From Real-World All-Comer Patients
15. Balloon Mitral Valvuloplasty
16. Association of N-terminal pro-brain natriuretic peptide with mortality in COVID-19: A systematic review and meta-analysis
17. TCT-447 Three-Year Follow-Up After Treatment of Coronary Artery Lesions Using Sirolimus-Coated Balloons: Insights From Real-World All-Comer Patients
18. TCT-500 Long-Term Safety and Efficacy of Sirolimus-Coated Balloon in Real-World Patients With In-Stent Restenosis
19. TCT-468 Safety and Efficacy Outcome After Implantation of a Novel Sirolimus-Eluting Stent in Real-World Patient Population: 3-Year Results From the en-Abl-e Registry
20. Spontaneous Renal Artery Dissection in COVID-19 Pneumonia: Potential Danger of Cytokine Storm
21. Two-year safety and efficacy of Indigenous Abluminus Sirolimus Eluting Stent. Does it differ amongst diabetics? – Data from en-ABLe- REGISTRY
22. Targeting "diabetic" coronary stenosis merging the properties of sirolimus coated balloon with sirolimus eluting stent
23. TCT CONNECT-258 Comparison of Clinical Outcomes Between Novel Sirolimus-Eluting Stent and Sirolimus-Coated Balloon for the Treatment of Patients With Diabetes Mellitus: Pooled Patient-Level Analysis
24. TCT CONNECT-255 Long-Term Outcome After Coronary Revascularization With Sirolimus-Coated Balloon in Patients With Small-Vessel Disease (≤2.75 mm): 3-Year Results From NANOLUTE Real-World Study
25. TCT CONNECT-253 3-Year Outcomes of Sirolimus-Coated Balloon Treatment in De Novo and In-Stent Restenotic Coronary Lesions
26. TCT CONNECT-380 2-Year Results of the Novel Sirolimus Eluting Stent in an All-Comer High-Risk Population
27. TCT CONNECT-289 3-Years Clinical Performance of Sirolimus Coated Balloon in Patients With Coronary In-Stent Restenosis: Results From Real-World Multi-Centre Experience
28. Consensus document: management of heart failure in type 2 diabetes mellitus
29. CRT-100.90 2-Years Follow-Up After Treatment of Coronary Artery Lesions Using Sirolimus-Coated Balloons: Insights From Real-World All-Comer Patients
30. CRT-100.93 To Evaluate Safety and Efficacy of Novel Sirolimus-Eluting Stent (DES+DCB) and Sirolimus-Coated Balloon for Treatment of Patients With Diabetes Mellitus
31. CRT-100.91 Clinical Outcomes in Real-World Patients Treated With a Novel Abluminal-Coated Sirolimus-Eluting Stent With Unique Fusion Coating
32. Targeting "diabetic" coronary artery disease merging the properties of sirolimus coated balloon with sirolimus eluting stent.
33. TCT-264 Clinical Outcome Post–Sirolimus-Coated Balloon Angioplasty in Patients With De Novo Lesions Located in Small-Vessel Arteries (≤2.75 mm): 2-Year Results From a Prospective Study
34. TCT-282 Predictors of Clinical Outcomes After Implantation of Novel Sirolimus-Eluting Stent in Real-World Patient Population
35. TCT-263 To Assess the Safety and Efficacy of Novel Drug-Coated Balloon in All Comers, Real-World Population
36. TCT-274 A Prospective Multicenter Study to Assess the Long-Term Safety and Efficacy of Sirolimus-Coated Balloon in Treatment of In-Stent Restenosis in Unselected Real-World Patients
37. TCT-627 Novel Sirolimus Eluting Stent With Fusion Coating Technology to Address the “Diabetes Issue”: 2-Year Result of the en-ABL e-Registry
38. TCTAP A-069 A Long-term Clinical Follow-up of Sirolimus Coated Balloon in Real World Population: Results from NANOLUTE Study
39. TCTAP A-068 Long-term Follow-up from the NANOLUTE Registry on the Performance of Sirolimus Coated Balloon for the Treatment of In-Stent Restenosis
40. LONG-TERM CLINICAL OUTCOME IN REAL-WORLD PATIENTS TREATED WITH A NOVEL ABLUMINAL COATED SIROLIMUS-ELUTING STENT WITH UNIQUE FUSION COATING
41. LONG TERM CLINICAL OUTCOME OF A NOVEL SIROLIMUS-ELUTING CORONARY STENT IN PATIENTS WITH ACUTE CORONARY SYNDROME
42. SIROLIMUS COATED BALLOON FOR THE MANAGEMENT OF CORONARY IN-STENT RESTENOSIS: LONG TERM CLINICAL RESULTS FROM NANOLUTE STUDY
43. LONG TERM CLINICAL OUTCOME OF A NOVEL SIROLIMUS-ELUTING CORONARY STENT WITH UNIQUE COATING TECHNOLOGY IN PATIENTS WITH DIABETES
44. LONG-TERM CLINICAL OUTCOME OF SIROLIMUS COATED BALLOON ANGIOPLASTY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS
45. Two-year safety and efficacy of Indigenous Abluminally Sirolimus Eluting stent. Does it differ amongst diabetics? -- Data from en-ABL e-REGISTRY.
46. Merging the properties of a sirolimus coated balloon with those of a bioresorbable polymer sirolimus eluting stent to address the "diabetes issue". Results from the En-Abl multicenter registry
47. TCT-264 Sirolimus Coated Balloon in The Treatment of Small Vessel Disease: Long Term Follow-up From The Indian Nanolute Registry
48. TCT-549 Long-term Clinical Outcomes after Implantation of Novel Abluminal Coated Sirolimus Eluting Stent in Real World Unselected Population: Update from en-ABL e-Registry
49. TCT-789 Outcomes after PCI with Novel Sirolimus-Eluting Stent with Unique Fusion Coating in Patients with Diabetes Mellitus
50. Cardiovascular risk factors and their association with carotid intima media thickness in children in Western India
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.